You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

European Nations Resume Using AstraZeneca COVID-19 Vaccine After Blot Clot Fears

HeadlineMar 19, 2021

About a dozen nations, including Germany, France, Italy and Spain, have resumed use of Oxford’s AstraZeneca vaccine, after Europe’s top regulator declared the shots safe and effective. The European Medicines Agency investigated 25 cases of rare blood clots among some 20 million people who’ve received AstraZeneca inoculations. It’s not known whether the vaccine caused the blood clots, and health officials say its benefits far outweigh its risks.

Meanwhile, the Biden administration said it plans to ship about 4 million doses of U.S.-made AstraZeneca vaccine to Mexico and Canada. The vaccine is not yet approved for use in the United States, and millions of vials have been piling up in U.S. warehouses, prompting criticism of “vaccine hoarding.” The White House says the vaccine shipments would have to be repaid, effectively making them a loan.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top